Gaining a Competitive Edge in Digital Health: A Top 20 Pharma Company’s Winning Strategy

Jennifer SayersCase Studies

The Situation
____________

Faced with an increasingly competitive landscape, a leading Top 20 pharmaceutical company recognized the need to stay ahead of the curve in digital health developments. To achieve this, they partnered with Sedulo Group to proactively monitor advancements in diagnostic kits, clinical trials, payer value, and hospital treatment algorithms. Sedulo Group’s mission was to identify opportunities that could accelerate the advancement of early pipeline assets, enhance clinical trial recruitment and execution, and contribute to improved patient outcomes.

The Solution
____________

Sedulo Group implemented a comprehensive research program tailored to the client’s specific needs. Over an eighteen-month period, the team 

conducted extensive desk research, strategic source interviews, and in-depth analysis to produce multiple executive-ready insights reports. Initially focusing on two key competitors, the program expanded to encompass five market leaders. Utilizing Sedulo Group’s Persistent Source Network™ and Conversational Interviewing Technique, our research specialists engaged directly with high-value industry sources, including analysts and business development personnel, while continuously monitoring market activities through publicly available information.

The Success
___________

The result was a series of executive-ready insights reports, delivered monthly, summarizing current findings and providing actionable insights with client-specific implications. Additionally, Sedulo provided email flash alerts to notify the client of time-sensitive developments. These comprehensive reports equipped the client with detailed findings and strategic insights to support key decisions.

Sedulo Group’s digital health partnership program scored each competitor’s digital health capabilities across 12 key categories, resulting in a cumulative comparative analysis. Umbrella categories included Translational Medicine, Acceleration of Clinical Trials, and Value creation and execution. This data-driven approach allowed them to understand their competitors’ strengths and weaknesses, enabling them to make informed strategic decisions and maintain a competitive edge in the digital health space.